<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01564680</url>
  </required_header>
  <id_info>
    <org_study_id>#201021</org_study_id>
    <nct_id>NCT01564680</nct_id>
  </id_info>
  <brief_title>Lornoxicam vs. Paracetamol After Lower Abdominal Surgery</brief_title>
  <official_title>Intravenous Lornoxicam is More Effective Than Paracetamol as a Supplemental Analgesic After Lower Abdominal Surgery; A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dammam University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dammam University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: The aim of this prospective, randomized, double-blind study is to determine the
      most effective supplemental analgesic, paracetamol or lornoxicam for postoperative pain
      relief after lower abdominal surgery.

      Methods: Sixty patients scheduled for lower abdominal surgery under general anesthesia were
      randomly allocated to receive either isotonic saline (Control group), intravenous paracetamol
      1 g every 6 h (Paracetamol group) or lornoxicam 16 mg then 8 mg after 12 h (Lornoxicam
      group). Additionally pain was treated postoperatively using morphine patient-controlled
      analgesia. Postoperative pain scores measured by the verbal pain score (VPS), morphine
      consumption and the incidence of side effects were measured at 1, 2, 4, 8, 12 and 24 hours
      postoperatively.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>24 hours</time_frame>
    <description>Postoperative pain scores measured by the verbal pain score (VPS)1, 2, 4, 8, 12 and 24 hours postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>pain was treated postoperatively using morphine patient-controlled analgesia. Morphine consumption was measured at 1, 2, 4, 8, 12 and 24 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of side-effects</measure>
    <time_frame>24 hours</time_frame>
    <description>incidence of side effects was measured at 1,2,4,8, 12, 24 hr postoperatively.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Lornoxicam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lornoxicam 16 mg will be given at skin closure and 8 mg will be given 12 hours postoperatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive normal saline at skin closure, at 6, 12, 18 hours postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paracetamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 gm of paracetamol will be given at skin closure, 6, 12, 18 hours postoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>normal saline</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>0.9 N sodium chloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>IV paracetamol infusion</description>
    <arm_group_label>Paracetamol</arm_group_label>
    <other_name>perfalgan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lornoxicam</intervention_name>
    <description>16 mg at skin closure and 8 mg 12 hours postoperative</description>
    <arm_group_label>Lornoxicam</arm_group_label>
    <other_name>xefo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  lower abdominal surgery

        Exclusion Criteria:

          -  body weight more than 150% of their ideal body weight

          -  history of significant cardiac, pulmonary, renal, hepatic or hematological disease;
             chronic drug or alcohol abuse; hypersensitivity to any of the studied drugs; bronchial
             asthma; gastritis or peptic ulcer; and pregnancy

          -  patients who received any analgesic drug a day before surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hany A Mowafi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dammam University, KFHU</name>
      <address>
        <city>Al-Khobar</city>
        <state>EP</state>
        <zip>31952</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2012</study_first_submitted>
  <study_first_submitted_qc>March 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2012</study_first_posted>
  <last_update_submitted>March 27, 2012</last_update_submitted>
  <last_update_submitted_qc>March 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lower abdominal surgery</keyword>
  <keyword>Paracetamol</keyword>
  <keyword>Lornoxicam</keyword>
  <keyword>Morphine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Lornoxicam</mesh_term>
    <mesh_term>Piroxicam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

